These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

711 related articles for article (PubMed ID: 23836234)

  • 41. GS-9669: a novel non-nucleoside inhibitor of viral polymerase for the treatment of hepatitis C virus infection.
    Gentile I; Buonomo AR; Zappulo E; Coppola N; Borgia G
    Expert Rev Anti Infect Ther; 2014 Oct; 12(10):1179-86. PubMed ID: 25096404
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Closing the Gap: The Challenges of Treating Hepatitis C Virus Genotype 3 Infection.
    Martin MT; Deming P
    Pharmacotherapy; 2017 Jun; 37(6):735-747. PubMed ID: 28374965
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis C virus-host interactions: the NS5A protein and the interferon/chemokine systems.
    Khabar KS; Polyak SJ
    J Interferon Cytokine Res; 2002 Oct; 22(10):1005-12. PubMed ID: 12433279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intrinsic Viral Factors Are the Dominant Determinants of the Hepatitis C Virus Response to Interferon Alpha Treatment in Chimeric Mice.
    Chen R; Kobewka M; Addison W; Lachance G; Tyrrell DL
    PLoS One; 2016; 11(1):e0147007. PubMed ID: 26765841
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The molecular biology of hepatitis C virus].
    Koutsoudakis G; Forns X; Pérez-Del-Pulgar S
    Gastroenterol Hepatol; 2013 Apr; 36(4):280-93. PubMed ID: 23490024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses.
    Shin EC; Han JW; Kang W; Kato T; Kim SJ; Zhong J; Kim S; Park SH; Sung PS; Watashi K; Park JY; Windisch MP; Oh JW; Wakita T; Han KH; Jang SK
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32168867
    [No Abstract]   [Full Text] [Related]  

  • 47. Emerging therapies for hepatitis C.
    Kim DY; Ahn SH; Han KH
    Gut Liver; 2014 Sep; 8(5):471-9. PubMed ID: 25228970
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interferon-free strategies with a nucleoside/nucleotide analogue.
    Feld JJ
    Semin Liver Dis; 2014 Feb; 34(1):37-46. PubMed ID: 24782257
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis C virus molecular evolution: transmission, disease progression and antiviral therapy.
    Preciado MV; Valva P; Escobar-Gutierrez A; Rahal P; Ruiz-Tovar K; Yamasaki L; Vazquez-Chacon C; Martinez-Guarneros A; Carpio-Pedroza JC; Fonseca-Coronado S; Cruz-Rivera M
    World J Gastroenterol; 2014 Nov; 20(43):15992-6013. PubMed ID: 25473152
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resistance to direct antiviral agents in patients with hepatitis C virus infection.
    Sarrazin C; Zeuzem S
    Gastroenterology; 2010 Feb; 138(2):447-62. PubMed ID: 20006612
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatitis C Virus.
    Pietschmann T; Brown RJP
    Trends Microbiol; 2019 Apr; 27(4):379-380. PubMed ID: 30709707
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics.
    Guedj J; Neumann AU
    J Theor Biol; 2010 Dec; 267(3):330-40. PubMed ID: 20831874
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens.
    Vespasiani-Gentilucci U; Galati G; Gallo P; De Vincentis A; Riva E; Picardi A
    World J Gastroenterol; 2015 Jun; 21(24):7412-26. PubMed ID: 26139987
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Virus-host interactions in hepatitis C virus infection: implications for molecular pathogenesis and antiviral strategies.
    Georgel P; Schuster C; Zeisel MB; Stoll-Keller F; Berg T; Bahram S; Baumert TF
    Trends Mol Med; 2010 Jun; 16(6):277-86. PubMed ID: 20537953
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-alpha2a/ribavirin therapy.
    Pugnale P; Herrmann E; Neumann AU; Pawlotsky JM; Schalm SW; Ferrari C; Homburger Y; Zeuzem S; Negro F;
    J Hepatol; 2008 Jun; 48(6):932-8. PubMed ID: 18433918
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New perspectives in HCV therapy: entry inhibitors.
    Donia M; Cacopardo B; Libra M; Scalia G; McCubrey JA; Nicoletti F
    Recent Pat Antiinfect Drug Discov; 2010 Nov; 5(3):181-94. PubMed ID: 20497122
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: safety, antiviral activity, resistance, and pharmacokinetics.
    Lawitz E; Sulkowski M; Jacobson I; Kraft WK; Maliakkal B; Al-Ibrahim M; Gordon SC; Kwo P; Rockstroh JK; Panorchan P; Miller M; Caro L; Barnard R; Hwang PM; Gress J; Quirk E; Mobashery N
    Antiviral Res; 2013 Sep; 99(3):214-20. PubMed ID: 23747481
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Boceprevir plus pegylated interferon/ribavirin to re-treat hepatitis C virus genotype 1 in HIV-HCV co-infected patients: final results of the Spanish BOC HIV-HCV Study.
    Laguno M; Von Wichmann MA; Van den Eynde E; Navarro J; Cifuentes C; Murillas J; Veloso S; Martínez-Rebollar M; Guardiola JM; Jou A; Gómez-Sirvent JL; Cervantes M; Pineda JA; López-Calvo S; Carrero A; Montes ML; Deig E; Tapiz A; Ruiz-Mesa JD; Cruceta A; de Lazzari E; Mallolas J
    Int J Infect Dis; 2016 Dec; 53():46-51. PubMed ID: 27815225
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-throughput approaches to unravel hepatitis C virus-host interactions.
    Colpitts CC; El-Saghire H; Pochet N; Schuster C; Baumert TF
    Virus Res; 2016 Jun; 218():18-24. PubMed ID: 26410623
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current progress in the treatment of chronic hepatitis C.
    Alexopoulou A; Papatheodoridis GV
    World J Gastroenterol; 2012 Nov; 18(42):6060-9. PubMed ID: 23155334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.